Thymoxamine reverses phenylephrine-induced mydriasis

Susan J. Relf, N. Ziai Gharagozloo, Gregory L. Skuta, Wallace L M Alward, Douglas Anderson, Richard F. Brubaker

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We performed a randomized double-masked evaluation of the alpha-adrenergic blocking agent thymoxamine (0.1%) as compared to placebo for the reversal of phenylephrineinduced mydriasis. Topically applied thymoxamine reversed the mydriasis from a single drop of 2.5% phenylephrine in 36 of 40 eyes (90%) within one hour. The mydriasis was completely reversed in 25 of 40 eyes (63%). Eyes with blue irides responded more quickly and more completely than did those with brown irides. The 40 contralateral eyes, which had also been dilated with phenylephrine, remained dilated or dilated further after receiving a placebo eyedrop. Twenty subjects (50%) reported mild transient ocular irritation upon instillation of thymoxamine. Thymoxamine was useful in individuals with narrow anterior chamber angles who were at risk of acute closed-angle glaucoma following dilation with an adrenergic agent.

Original languageEnglish
Pages (from-to)251-255
Number of pages5
JournalAmerican Journal of Ophthalmology
Volume106
Issue number15
DOIs
StatePublished - Sep 15 1988

Fingerprint

Moxisylyte
Mydriasis
Phenylephrine
Iris
Placebos
Adrenergic alpha-Antagonists
Angle Closure Glaucoma
Ophthalmic Solutions
Anterior Chamber
Adrenergic Agents
Dilatation

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Relf, S. J., Gharagozloo, N. Z., Skuta, G. L., Alward, W. L. M., Anderson, D., & Brubaker, R. F. (1988). Thymoxamine reverses phenylephrine-induced mydriasis. American Journal of Ophthalmology, 106(15), 251-255. https://doi.org/10.1016/0002-9394(88)90356-X

Thymoxamine reverses phenylephrine-induced mydriasis. / Relf, Susan J.; Gharagozloo, N. Ziai; Skuta, Gregory L.; Alward, Wallace L M; Anderson, Douglas; Brubaker, Richard F.

In: American Journal of Ophthalmology, Vol. 106, No. 15, 15.09.1988, p. 251-255.

Research output: Contribution to journalArticle

Relf, SJ, Gharagozloo, NZ, Skuta, GL, Alward, WLM, Anderson, D & Brubaker, RF 1988, 'Thymoxamine reverses phenylephrine-induced mydriasis', American Journal of Ophthalmology, vol. 106, no. 15, pp. 251-255. https://doi.org/10.1016/0002-9394(88)90356-X
Relf SJ, Gharagozloo NZ, Skuta GL, Alward WLM, Anderson D, Brubaker RF. Thymoxamine reverses phenylephrine-induced mydriasis. American Journal of Ophthalmology. 1988 Sep 15;106(15):251-255. https://doi.org/10.1016/0002-9394(88)90356-X
Relf, Susan J. ; Gharagozloo, N. Ziai ; Skuta, Gregory L. ; Alward, Wallace L M ; Anderson, Douglas ; Brubaker, Richard F. / Thymoxamine reverses phenylephrine-induced mydriasis. In: American Journal of Ophthalmology. 1988 ; Vol. 106, No. 15. pp. 251-255.
@article{7162e1ef78e8427eb6b1f5cc4ed66a04,
title = "Thymoxamine reverses phenylephrine-induced mydriasis",
abstract = "We performed a randomized double-masked evaluation of the alpha-adrenergic blocking agent thymoxamine (0.1{\%}) as compared to placebo for the reversal of phenylephrineinduced mydriasis. Topically applied thymoxamine reversed the mydriasis from a single drop of 2.5{\%} phenylephrine in 36 of 40 eyes (90{\%}) within one hour. The mydriasis was completely reversed in 25 of 40 eyes (63{\%}). Eyes with blue irides responded more quickly and more completely than did those with brown irides. The 40 contralateral eyes, which had also been dilated with phenylephrine, remained dilated or dilated further after receiving a placebo eyedrop. Twenty subjects (50{\%}) reported mild transient ocular irritation upon instillation of thymoxamine. Thymoxamine was useful in individuals with narrow anterior chamber angles who were at risk of acute closed-angle glaucoma following dilation with an adrenergic agent.",
author = "Relf, {Susan J.} and Gharagozloo, {N. Ziai} and Skuta, {Gregory L.} and Alward, {Wallace L M} and Douglas Anderson and Brubaker, {Richard F.}",
year = "1988",
month = "9",
day = "15",
doi = "10.1016/0002-9394(88)90356-X",
language = "English",
volume = "106",
pages = "251--255",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "15",

}

TY - JOUR

T1 - Thymoxamine reverses phenylephrine-induced mydriasis

AU - Relf, Susan J.

AU - Gharagozloo, N. Ziai

AU - Skuta, Gregory L.

AU - Alward, Wallace L M

AU - Anderson, Douglas

AU - Brubaker, Richard F.

PY - 1988/9/15

Y1 - 1988/9/15

N2 - We performed a randomized double-masked evaluation of the alpha-adrenergic blocking agent thymoxamine (0.1%) as compared to placebo for the reversal of phenylephrineinduced mydriasis. Topically applied thymoxamine reversed the mydriasis from a single drop of 2.5% phenylephrine in 36 of 40 eyes (90%) within one hour. The mydriasis was completely reversed in 25 of 40 eyes (63%). Eyes with blue irides responded more quickly and more completely than did those with brown irides. The 40 contralateral eyes, which had also been dilated with phenylephrine, remained dilated or dilated further after receiving a placebo eyedrop. Twenty subjects (50%) reported mild transient ocular irritation upon instillation of thymoxamine. Thymoxamine was useful in individuals with narrow anterior chamber angles who were at risk of acute closed-angle glaucoma following dilation with an adrenergic agent.

AB - We performed a randomized double-masked evaluation of the alpha-adrenergic blocking agent thymoxamine (0.1%) as compared to placebo for the reversal of phenylephrineinduced mydriasis. Topically applied thymoxamine reversed the mydriasis from a single drop of 2.5% phenylephrine in 36 of 40 eyes (90%) within one hour. The mydriasis was completely reversed in 25 of 40 eyes (63%). Eyes with blue irides responded more quickly and more completely than did those with brown irides. The 40 contralateral eyes, which had also been dilated with phenylephrine, remained dilated or dilated further after receiving a placebo eyedrop. Twenty subjects (50%) reported mild transient ocular irritation upon instillation of thymoxamine. Thymoxamine was useful in individuals with narrow anterior chamber angles who were at risk of acute closed-angle glaucoma following dilation with an adrenergic agent.

UR - http://www.scopus.com/inward/record.url?scp=0023694967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023694967&partnerID=8YFLogxK

U2 - 10.1016/0002-9394(88)90356-X

DO - 10.1016/0002-9394(88)90356-X

M3 - Article

C2 - 2971321

AN - SCOPUS:0023694967

VL - 106

SP - 251

EP - 255

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 15

ER -